Clinical Scientist, Sepsis

Company Description

Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office in Stockholm, Sweden, Sobi also has premises in Basel, Switzerland. You can find more information about Sobi at

The Clinical Scientist, Sepsis is accountable for the design, execution and reporting of Sobi-sponsored clinical studies within the sepsis therapeutic area, and acts as a scientific and medical subject-matter expert for the assigned development programme across operational, regulatory and drug safety matters.

The role operates in a therapeutic area characterised by high unmet need, high background mortality, heterogeneous patient populations and no established precedent of approved disease‑modifying therapies. The position therefore carries an explicit expectation of methodological rigour: precise definition of target populations and endpoints, defensible assumptions underpinning trial design, and transparent handling of uncertainty in interpreting emerging data.

The position reports to the TA Head, Sepsis and works within the Medical Development Team and Clinical Study Teams, in close partnership with Clinical Operations, Biostatistics, Regulatory Affairs, Patient Safety, Translational Medicine and external investigators.

• Clinical development strategy and study design
• Provide clinical, scientific and strategic input to clinical development plans for the assigned sepsis programme(s), adhering to the highest scientific and ethical standards.
• Contribute to the definition of the target population, including immune phenotype / endotype and biomarker-based enrichment strategies, and to the selection of clinically meaningful primary and secondary endpoints (for example all-cause mortality at a pre-specified day, organ support-free days, change in organ dysfunction scores).
• Contribute to the evaluation of design options appropriate to acute critical care research, including adaptive, platform and Bayesian approaches, and document the assumptions, effect-size estimates and event-rate expectations on which sample size and feasibility depend.
• Collaborate with the Medical Development Lead (MDL) and Medical Program Lead (MPL) on the overall scientific and medical development strategy.
• Study execution, medical oversight and reporting
• Act as the clinical scientific lead for assigned Sobi-sponsored studies. Where the incumbent holds a medical degree and the responsibility is formally delegated, act as Medical Director / Medical Monitor for those studies.
• Take responsibility for planning, designing, conducting (including medical monitoring) and reporting Sobi-sponsored studies, in close collaboration with Clinical Operations, study teams, Regulatory Affairs, Patient Safety and other cross-functional HQ functions.
• Author clinical study protocols and clinical study reports, and contribute to statistical analysis plans, informed consent templates and other core study documents.
• Support operational feasibility specific to intensive care and emergency department settings, including short screening and treatment windows, out-of-hours randomisation, deferred or emergency consent processes where legally permitted, and biomarker and central laboratory logistics.
• Perform ongoing medical review of emerging safety and efficacy data in a population with high background morbidity and mortality, supporting attribution of adverse events, safety review committee and DSMB interactions, and pre-specified interim analyses.
• Participate in investigator meetings, site training and other study-related activities.
• Regulatory and submission activities
• Provide strategic and operational clinical development expertise in interactions with regulatory authorities for assigned products and projects, as requested and appropriate.
• Contribute high-quality scientific and medical input to the clinical components of regulatory submissions and to responses to Health Authority questions, including scientific advice, IND applications and marketing authorisation applications.
• Maintain current awareness of applicable regulatory guidance and precedent relevant to acute critical care and sepsis trials, and of expedited pathway options where relevant.
• External scientific engagement
• Interact and consult with key opinion leaders in critical care, infectious diseases and…